Evidence map›Paper›PMID 37490504›Full record

ArticlePloS one2023

Performance of cotton expressing Cry1Ac, Cry1F and Vip3Aa19 insecticidal proteins against Helicoverpa armigera, H. zea and their hybrid progeny, and evidence of reduced susceptibility of a field population of H. zea to Cry1 and Vip3Aa in Brazil.

Luiz H Marques, Tamylin K Ishizuka, Renata R Pereira, Ademar N Istchuk, Jaedino Rossetto, Valeria F Moscardini, Oscar A N B E Silva, Antonio C Santos, Timothy Nowatzki, Mark L Dahmer and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Luiz H MarquesCorteva Agriscience, Mogi Mirim, SP, Brazil.ORCID 0000-0002-2029-2587
Tamylin K IshizukaCorteva Agriscience, Mogi Mirim, SP, Brazil.
Renata R PereiraCorteva Agriscience, Mogi Mirim, SP, Brazil.
Ademar N IstchukCorteva Agriscience, Mogi Mirim, SP, Brazil.ORCID 0000-0001-8174-5079
Jaedino RossettoCorteva Agriscience, Mogi Mirim, SP, Brazil.
Valeria F MoscardiniCorteva Agriscience, Mogi Mirim, SP, Brazil.
Oscar A N B E SilvaCorteva Agriscience, Mogi Mirim, SP, Brazil.
Antonio C SantosCorteva Agriscience, Mogi Mirim, SP, Brazil.
Timothy NowatzkiCorteva Agriscience, Johnston, IA, United States of America.ORCID 0000-0002-0157-997X
Mark L DahmerCorteva Agriscience, Johnston, IA, United States of America.
Amit SethiCorteva Agriscience, Johnston, IA, United States of America.
Nicholas P StorerCorteva Agriscience, Johnston, IA, United States of America.
Pablo C GontijoInstituto Federal Goiano (IF Goiano), Campus Rio Verde, Rio Verde, GO, Brazil.
Jacob C NettoInstituto Mato-grossense do Algodão (IMAmt), Primavera do Leste, MT, Brazil.ORCID 0000-0003-3735-0998
Marlon A G WeschenfelderFederal University of Santa Maria (UFSM), Santa Maria, RS, Brazil.
Poliana G de AlmeidaFederal University of Santa Maria (UFSM), Santa Maria, RS, Brazil.
Oderlei BernardiFederal University of Santa Maria (UFSM), Santa Maria, RS, Brazil.ORCID 0000-0001-9320-1642
Corteva (United States) · USUniversidade Federal de Santa Maria · BRInstituto Federal Goiano · BRInstituto Geológico · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetically modified cotton DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 expressing Cry1Ac, Cry1F and Vip3Aa19 from Bacillus thuringiensis Berliner (Bt) has been cultivated in Brazil since the 2020/2021 season. Here, we assessed the performance of DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 cotton expressing Cry1Ac, Cry1F and Vip3Aa19 against Helicoverpa armigera (Hübner), Helicoverpa zea (Boddie), and their hybrid progeny. We also carried out evaluations with DAS-21023-5 × DAS-24236-5 cotton containing Cry1Ac and Cry1F. In leaf-disk bioassays, DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 was effective in controlling neonates from laboratory colonies of H. armigera, H. zea and the hybrid progeny (71.9%-100% mortality). On floral bud bioassays using L2 larvae, H. zea presented complete mortality, whereas H. armigera and the hybrid progeny showed <55% mortality. On DAS-21023-5 × DAS-24236-5 cotton, the mortality of H. armigera on leaf-disk and floral buds ranged from 60% to 73%, whereas mortality of hybrids was <46%. This Bt cotton caused complete mortality of H. zea larvae from a laboratory colony in the early growth stages, but mortalities were <55% on advanced growth stages and on floral buds. In field studies conducted from 2014 to 2019, DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 cotton was also effective at protecting plants against H. armigera. In contrast, a population of H. zea collected in western Bahia in 2021/2022 on Bt cotton expressing Cry1 and Vip3Aa proteins, showed 63% mortality after 30 d, with insects developing into fifth and sixth instars, on DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 cotton. We conclude that H. armigera, H. zea, and their hybrid progeny can be managed with DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 cotton; however we found the first evidence in Brazil of a significant reduction in the susceptibility to DAS-21023-5 × DAS-24236-5 × SYN-IR102-7 cotton of a population of H. zea collected from Bt cotton in Bahia in 2021/2022.

Indexed as

InsecticidesMothsAnimalsBacillus thuringiensis ToxinsBacterial ProteinsBrazilEndotoxinsGossypiumHemolysin ProteinsHumansInfant, NewbornLarvaPlants, Genetically ModifiedZea maysBacillus thuringiensis ToxinsBacterial ProteinsEndotoxinsHemolysin ProteinsInsecticides

Identifiers

PMID37490504
PMCPMC10368247
OpenAlexW4385237027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.